Related Experiment Video
Updated: Jan 20, 2026

Author Spotlight: Optimizing CFU Determination for Efficient Assessment of TB Vaccine Efficacy and Antigen Presentation Analysis
Published on: July 28, 2023
Vaccine efficacy and control measures in pertussis
1PHLS Communicable Disease Surveillance Centre, Welsh Unit, Roath, Cardiff.
Pertussis vaccine efficacy was estimated during an outbreak. Using notified cases yielded 88% efficacy, but including all coughing children lowered it to 68%, suggesting bias in notified case data.
Area of Science:
- * Epidemiology and Public Health
- * Vaccinology and Immunology
Background:
- * Pertussis (whooping cough) outbreaks pose a significant public health concern, particularly in school settings.
- * Accurate estimation of pertussis vaccine efficacy is crucial for public health policy and vaccination program evaluation.
Purpose of the Study:
- * To estimate the efficacy of the pertussis vaccine during a community outbreak.
- * To assess potential biases in vaccine efficacy estimates based on different case ascertainment methods.
Main Methods:
- * Conducted a study during a pertussis outbreak in primary schoolchildren in Pembrokeshire.
- * Compared vaccination status between notified pertussis cases and children with prolonged coughing symptoms (≥2 weeks).
Main Results:
- * Pertussis vaccine efficacy estimated at 88% using notified cases.
- * Efficacy estimate decreased to 68% when including all children with prolonged coughing bouts.
- * Notified cases were significantly less likely to have received the pertussis vaccination compared to other symptomatic children.
Conclusions:
- * Vaccine efficacy estimates based solely on notified cases may be biased.
- * Even lower efficacy estimates underscore the importance of pertussis immunization.
- * Increased efforts to improve pertussis vaccination coverage are highly recommended.
More Related Videos
Related Concept Videos
06:26Micro-Colony Forming Unit Assay for Efficacy Evaluation of Vaccines Against Tuberculosis
07:33Preparation, Characteristics, Toxicity, and Efficacy Evaluation of the Nasal Self-Assembled Nanoemulsion Tumor Vaccine In Vitro and In Vivo
08:52Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
Vaccinations
04:51Measuring Immunoglobulin G Levels Against a Test Vaccine in a Mouse Serum
08:18Evaluation of Vaccine-Induced Immunity Against Bacterial Infection in a Mouse Model

